Genetic landscape of patients with ALK-rearranged non–small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 study

Autor: Tan, D.S-W., Thomas, M., Kim, D-W., Szpakowski, S., Urban, P., Mehra, R., Chow, L.Q.M., Sharma, S., Solomon, B.J., Felip, E., Camidge, D.R., Vansteenkiste, J., Petruzzelli, L., Pantano, S., Shaw, A.T.
Zdroj: In Lung Cancer January 2022 163:7-13
Databáze: ScienceDirect